Closing arguments in the first trial of Philadelphia’s Risperdal mass-tort actions focused largely on attacking the testimony and backgrounds of the experts.
Plaintiffs attorney Thomas R. Kline of Kline & Specter referenced a defense expert who came from Alabama as “Dr. Alabama,” and argued the doctor was less qualified than Kline’s experts. However, during the defense’s portion of the arguments, counsel for Janssen Pharmaceuticals, the defendant in the case, referred to the plaintiff’s experts as “regulars on the litigation circuit.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
